Publications by authors named "Steven Hager"

Claim this Profile
V
Validation of the FACIT-Fatigue scale in patients with locally advanced or metastatic breast cancer.
Alessandra Fabi, Steven Hager, Laura Lourdes, Chiara Gandini, Elizabeth M Gavioli

Oncologist· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Garsorasib, a KRAS G12C inhibitor, with or without cetuximab, an EGFR antibody, in colorectal cancer cohorts of a phase II trial in advanced solid tumors with KRAS G12C mutation.
Dan-Yun Ruan, Hao-Xiang Wu, Ye Xu, Pamela N Munster, Yanhong Deng, Steven Hager

Signal Transduct Target Ther· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 2 study of add-on parsaclisib for patients with myelofibrosis and suboptimal response to ruxolitinib: final results.
Abdulraheem Yacoub, Uma Borate, Raajit K Rampal, Haris Ali, Eunice S Wang, Steven Hager

Blood Adv· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chromatographic capture of cells to achieve single stage clarification in recombinant protein purification.
Aaron Almeida, David Chau, Thomas Coolidge, Hani El-Sabbahy, Steven Hager

Biotechnol Prog· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Rare Presentation of a Non-Asian Female With Metastatic Non-small-cell Lung Cancer Harboring L747P Mutation With Clinical Response to Multi-targeted Epigenetic and Inhibition.
Samia S Messeha, Mohammad A Nezami, Steven Hager, Karam F A Soliman

Anticancer Res· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An open-label, dose-ranging study of Rolontis, a novel long-acting myeloid growth factor, in breast cancer.
Jeffrey L Vacirca, Arlene Chan, Klára Mezei, Clarence S Adoo, Zsuzsanna Pápai, Steven J Hager

Cancer Med· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II study of gemcitabine and bevacizumab as first-line treatment in taxane-pretreated, HER2-negative, locally recurrent or metastatic breast cancer.
Rachel Borson, Graydon Harker, James Reeves, Thaddeus Beck, Steven Hager

Clin Breast Cancer· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Carboplatin plus gemcitabine repeating doublet therapy in recurrent breast cancer.
Robert A Nagourney, Marshall Flam, John Link, Steven Hager, Jonathan Blitzer

Clin Breast Cancer· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis